Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer

JAMA Oncol. 2018 Apr 1;4(4):585. doi: 10.1001/jamaoncol.2017.0487.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bone Density Conservation Agents*
  • Bone and Bones
  • Breast Neoplasms*
  • Diphosphonates
  • Female
  • Humans
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Zoledronic Acid